Evidence map›Paper›PMID 29912774›Full record

ArticleJournal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases2018

Depressive Symptoms Are Associated With Low Treatment Adherence in African American Individuals With Systemic Lupus Erythematosus.

Erica Heiman, S Sam Lim, Gaobin Bao, Cristina Drenkard

Abstract read
In one paragraph

Article in Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Patient Perception of Depressive Symptoms in Rheumatic Diseases: A Cross-sectional Survey.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2022
    Article
  13. Article
  14. Article
  15. Lupus Cohorts.Rheumatic diseases clinics of North America · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Erica HeimanFrom the Divisions of General Medicine and Geriatrics and.
S Sam LimRheumatology, Department of Medicine, Emory University, Atlanta, GA.
Gaobin BaoRheumatology, Department of Medicine, Emory University, Atlanta, GA.
Cristina DrenkardRheumatology, Department of Medicine, Emory University, Atlanta, GA.

Funding

The Georgians Organized Against Lupus (GOAL) Cohort: Advancing Health DisparitiesU01DP005119 · DP · EMORY UNIVERSITY · PI DRENKARD, CRISTINA MARTA, LIM, SUNG SAM · 2014 to 2018
$4.8M
Psychosocial Factors and Lupus Disease Progression Among African American WomenR01AR065493 · NIAMS · UNIV OF MARYLAND, COLLEGE PARK · PI CHAE, H. DAVID, LIM, SUNG SAM · 2014 to 2022
$4.2M
Social Stressors and Atherosclerosis in African-American Women with LupusR01AR070898 · NIAMS · EMORY UNIVERSITY · PI LEWIS, TENÉ T · 2016 to 2020
$3.3M
A widespread self-management education program to reduce health disparities in African American women with systemic lupus erythematosusR01MD010455 · NIMHD · EMORY UNIVERSITY · PI DRENKARD, CRISTINA MARTA · 2016 to 2020
$1.9M
ACL HHS U01DP005119NCCDPHP CDC HHS U01 DP005119NIAMS NIH HHS R01 AR065493NIAMS NIH HHS R01 AR070898NIMHD NIH HHS R01 MD010455
6 · The paper itself

Abstract

objectiveAfrican American (AA) people with systemic lupus erythematosus (SLE) are at high morbidity and mortality risk, and they often require multiple medications. Low medication adherence is a highly prevalent, multidimensional problem associated with poor outcomes in people with SLE. Depression, a predictor of low adherence in people with chronic conditions, has been described in over 35% of AAs with SLE. We hypothesized that depressive symptoms would be increasingly associated with low adherence in this population.

methodsResearch subjects predominantly belong to the Georgians Organized Against Lupus cohort, a population-based cohort of predominantly AA individuals with SLE in the Atlanta metropolitan area. Medication adherence and severity of depressive symptoms were measured using validated self-reported tools: the 8-item Morisky Medication Adherence Scale and the 9-item Patient Health Questionnaire, respectively. We used univariate and multivariate logistic regression to examine the odds ratios of low medication adherence across individuals with increasing severity of depressive symptoms.

resultsAmong 632 AA SLE participants, 336 (54%) reported low medication adherence and 217 (34.6%) reported "moderate" or "severe" depressive symptoms. In univariate logistic regression, significant risk factors for low adherence were depressive symptoms, low self-efficacy, poor satisfaction with care, female sex, younger age, hurried patient-physician communication, poorer shared decision-making, less compassionate physician communication style, poor/fair health, and higher disease activity score. In multivariate regression, younger age, female sex, and more severe depressive symptoms were associated with low medication adherence.

conclusionsThis is the first study to examine factors associated with low medication adherence among a population-based cohort of AA individuals with SLE. Depression was a strong correlate of low medication adherence. Mental health interventions aiming to address and treat depression may increase medication adherence.

Indexed as

Black or African AmericanCross-Sectional StudiesDepressionFemaleGeorgiaHumansLupus Erythematosus, SystemicMaleMedication AdherenceMiddle Aged

Identifiers

PMID29912774
PMCPMC6487191

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.